ロード中...
Checkpoint inhibitors in hematological malignancies
Inhibitory molecules such as PD-1, CTLA-4, LAG-3, or TIM-3 play a role to keep a balance in immune function. However, many cancers exploit such molecules to escape immune surveillance. Accumulating data support that their functions are dysregulated in lymphoid neoplasms, including plasma cell myelom...
保存先:
| 出版年: | J Hematol Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5422942/ https://ncbi.nlm.nih.gov/pubmed/28482851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0474-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|